A Cross-Sectional Study for Evaluation of KRAS and BRAF Mutations by Reverse Dot Blot, PCR-RFLP, and Allele-Specific PCR Methods Among Patients with Colorectal Cancer.
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer.
Nature Communications
Xue, Yibo Y; Meehan, Brian B; Fu, Zheng Z; Wang, Xue Qing D XQD; Fiset, Pierre Olivier PO; Rieker, Ralf R; Levins, Cameron C; Kong, Tim T; Zhu, Xianbing X; Morin, Geneviève G; Skerritt, Lashanda L; Herpel, Esther E; Venneti, Sriram S; Martinez, Daniel D; Judkins, Alexander R AR; Jung, Sungmi S; Camilleri-Broet, Sophie S; Gonzalez, Anne V AV; Guiot, Marie-Christine MC; Lockwood, William W WW; Spicer, Jonathan D JD; Agaimy, Abbas A; Pastor, William A WA; Dostie, Josée J; Rak, Janusz J; Foulkes, William D WD; Huang, Sidong S
Integrative omics analyses broaden treatment targets in human cancer.
Genome Medicine
Sengupta, Sohini S; Sun, Sam Q SQ; Huang, Kuan-Lin KL; Oh, Clara C; Bailey, Matthew H MH; Varghese, Rajees R; Wyczalkowski, Matthew A MA; Ning, Jie J; Tripathi, Piyush P; McMichael, Joshua F JF; Johnson, Kimberly J KJ; Kandoth, Cyriac C; Welch, John J; Ma, Cynthia C; Wendl, Michael C MC; Payne, Samuel H SH; Fenyö, David D; Townsend, Reid R RR; Dipersio, John F JF; Chen, Feng F; Ding, Li L
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma.
Oncogene
Po, A A; Silvano, M M; Miele, E E; Capalbo, C C; Eramo, A A; Salvati, V V; Todaro, M M; Besharat, Z M ZM; Catanzaro, G G; Cucchi, D D; Coni, S S; Di Marcotullio, L L; Canettieri, G G; Vacca, A A; Stassi, G G; De Smaele, E E; Tartaglia, M M; Screpanti, I I; De Maria, R R; Ferretti, E E
ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma.
Oncotarget
Hutchinson, Katherine E KE; Johnson, Douglas B DB; Johnson, Adam S AS; Sanchez, Violeta V; Kuba, Maria M; Lu, Pengcheng P; Chen, Xi X; Kelley, Mark C MC; Wang, Qingguo Q; Zhao, Zhongming Z; Kris, Mark M; Berger, Michael F MF; Sosman, Jeffrey A JA; Pao, William W
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.
Molecular Cancer
Imamura, Yu Y; Lochhead, Paul P; Yamauchi, Mai M; Kuchiba, Aya A; Qian, Zhi Rong ZR; Liao, Xiaoyun X; Nishihara, Reiko R; Jung, Seungyoun S; Wu, Kana K; Nosho, Katsuhiko K; Wang, Yaoyu E YE; Peng, Shouyong S; Bass, Adam J AJ; Haigis, Kevin M KM; Meyerhardt, Jeffrey A JA; Chan, Andrew T AT; Fuchs, Charles S CS; Ogino, Shuji S
Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approach.
The American Journal Of Surgical Pathology
Lasota, Jerzy J; Kowalik, Artur A; Wasag, Bartosz B; Wang, Zeng-Feng ZF; Felisiak-Golabek, Anna A; Coates, Tiffany T; Kopczynski, Janusz J; Gozdz, Stanislaw S; Miettinen, Markku M
Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition.
International Journal Of Cancer
Mayes, Patrick A PA; Degenhardt, Yan Y YY; Wood, Andrew A; Toporovskya, Yana Y; Diskin, Sharon J SJ; Haglund, Elizabeth E; Moy, Christopher C; Wooster, Richard R; Maris, John M JM